Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab in nasal polyposis with comorbid asthma
2006-003524-11Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Aug 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of omalizumab in chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma, sponsored by Ghent University Hospital. Primary endpoints: Primary: Effect of omalizumab on nasal polyp size and Primary: Evolution of nasal polyps compared to baseline. Started Aug 2006; status: completed.
02
Drugs
omalizumab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)asthma
Beyond the preview
Go deeper on 2006-003524-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003524-11.